Sporting events are no longer the most preferred target for terrorists, according to the Department of Homeland Security. Outdoor events, conferences, festivals, and other events featuring public figures are all vulnerable. And with over a thousand different-level attacks since 2015, it’s no surprise that safety and security are among the top concerns for event professionals.
Biosimilars and Biobetters
SMi’s 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance through technical case studies and practical advice from leading biosimilar and regulatory players including Harvest Moon Pharmaceuticals USA Inc, GfK, MHRA, Selecta Biosciences, Cinfa Biotech GmbH, Norwegian Medicines Agency and more. Unique perspectives will be shared on: • Evolving biosimilar regulatory landscape • Market access and product commercialisation barriers • Global marketing developments, including a focus on emerging market trends • In-depth protein characterisation and analytical comparability to efficiently and effectively collect data